Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
Clinical trial NCT05513976 · UNKNOWN
Trial details
- NCT number
- NCT05513976
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2023-05-30
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.